Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Avalo Therapeutics (AVTX) Debt Ratio (2016 - 2025)

Avalo Therapeutics filings provide 11 years of Debt Ratio readings, the most recent being 0.0 for Q2 2025.

  • On a quarterly basis, Debt Ratio changed N/A to 0.0 in Q2 2025 year-over-year; TTM through Jun 2025 was 0.0, a N/A change, with the full-year FY2024 number at 0.0, changed N/A from a year prior.
  • Debt Ratio hit 0.0 in Q2 2025 for Avalo Therapeutics, up from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.58 in Q2 2022 to a low of 0.0 in Q4 2024.
  • Median Debt Ratio over the past 5 years was 0.35 (2022), compared with a mean of 0.27.
  • The widest YoY moves for Debt Ratio: up 1.26% in 2022, down 1.26% in 2022.
  • Avalo Therapeutics' Debt Ratio stood at 0.41 in 2021, then fell by 1.26% to 0.4 in 2022, then dropped by 28.51% to 0.29 in 2023, then plummeted by 99.17% to 0.0 in 2024, then rose by 22.39% to 0.0 in 2025.
  • The last three reported values for Debt Ratio were 0.0 (Q2 2025), 0.0 (Q1 2025), and 0.0 (Q4 2024) per Business Quant data.